Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
XHQLX:US
NASDAQ GM
29.64
USD
0.03
0.10%
As of 09:29:30 ET on 07/30/2015.
Fund Type
Closed-End Fund
52Wk Range
21.59 - 30.94
1 Yr Return
46.62%
YTD Return
22.26%
Previous Close
29.61
52Wk Range
21.59 - 30.94
1 Yr Return
46.62%
YTD Return
22.26%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/30/2015)
29.64
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Last Dividend (on 05/22/2015)
0.54
Dividend Indicated Gross Yield
7.29%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
1.05%
Expense Ratio
1.32%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 436.32 k 50.30 m 9.58
Gilead Sciences Inc 443.12 k 43.48 m 8.28
Biogen Inc 69.08 k 29.17 m 5.56
Regeneron Pharmaceuticals Inc 54.52 k 24.62 m 4.69
Incyte Corp 259.92 k 23.82 m 4.54
Alexion Pharmaceuticals Inc 127.80 k 22.15 m 4.22
Teva Pharmaceutical Industries 287.32 k 17.90 m 3.41
Amgen Inc 107.12 k 17.12 m 3.26
Vertex Pharmaceuticals Inc 138.16 k 16.30 m 3.10
BioMarin Pharmaceutical Inc 128.43 k 16.01 m 3.05
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500